Akshata Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 4.93 Cr
- Revenue Growth -9.71%
- Profit Growth -8.03%
- Ebitda -66.19%
- Net Worth -96.52%
- Total Assets -7.73%
About Akshata Pharma
Akshata Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 March 2005 and has a history of 19 years and ten months. Its registered office is in Belgaum, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹4.93 Cr.
Sivarama Pilli and Radha Sivarama serve as directors at the Company.
Company Details
- Location
Belgaum, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24233KA2005PTC035745
- Company No.
035745
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2005
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Akshata Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivarama Pilli  | Director | 03-Mar-2005 | Current |
| Radha Sivarama | Director | 02-Jul-2007 | Current |
Financial Performance of Akshata Pharma.
Akshata Pharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 9.71% decrease. The company also saw a slight decrease in profitability, with a 8.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 96.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akshata Pharma?
In 2020, Akshata Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹49.25 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.93 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2015 | Others | ₹4.93 Cr | Open |
How Many Employees Work at Akshata Pharma?
Unlock and access historical data on people associated with Akshata Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akshata Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akshata Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.